BRCA1 mutations

Related by string. BRCA1 mutation * : BRCA1 BRCA2 . BRCA1 gene mutation . genes BRCA1 . gene BRCA1 . breast cancer genes BRCA1 . faulty BRCA1 gene . BRCA1 gene . mutated BRCA1 / Mutations . Mutation : gene mutation . gene mutations . G#D mutation . inherited mutations . genetic mutations identical . activating mutations . spontaneous mutation . EGFR mutations * BRCA1 mutation carriers *

Related by context. All words. (Click for frequent words.) 79 BRCA2 mutations 75 BRCA mutations 75 BRCA mutation 74 BRCA2 mutation 72 BRCA2 carriers 72 BRCA1 mutation 72 atypical hyperplasia 70 mutated BRCA1 70 endometrial cancers 70 BRCA2 mutation carriers 69 advanced adenomas 69 APOE e4 69 APOE4 68 noncarriers 68 BRCA gene mutation 68 BRCA1 68 germline mutations 68 advanced adenoma 68 colorectal neoplasia 68 BRCA1 mutation carriers 68 HNPCC 68 BRCA1 gene 68 BRCA2 gene mutation 67 nonmelanoma skin cancers 67 BRCA gene mutations 67 TGFBR1 * 6A 67 subclinical hyperthyroidism 67 APOE allele 67 p# mutations 67 ApoE4 67 ApoE4 gene 67 renal cell carcinomas 66 prostate cancer CaP 66 KRAS mutations 66 narcolepsy cataplexy 66 BRCA2 gene mutations 66 oophorectomy 66 subclinical hypothyroidism 66 MTHFR 66 ApoE4 allele 65 estrogen receptor negative 65 adenomatous polyps 65 chlamydial infection 65 faulty BRCA2 gene 65 BRCA2 gene 65 polycystic ovary syndrome PCOS 65 Li Fraumeni 65 BRCA2 genetic mutations 65 atypia 65 ductal breast cancer 65 LQTS 65 colorectal polyps 65 postmenopausal breast cancer 65 pCR 65 PTPN# 65 inherited mutations 65 BRCA mutation carriers 64 GBA mutations 64 advanced neoplasia 64 lobular breast cancer 64 MYCN amplification 64 basal cell nevus syndrome 64 placental malaria 64 APOL1 64 genes BRCA1 64 testicular germ cell 64 breast cancer genes BRCA1 64 pancreatic adenocarcinoma 64 familial pancreatic cancer 64 elevated CRP 64 salpingo oophorectomy 64 APOE gene 64 contralateral breast cancer 64 HNSCC 64 BRCA2 64 SIDS infants 64 MSH2 64 MGUS 64 PALB2 64 APOE ε4 64 adenoma 64 MLH1 63 EGFR mutations 63 lobular cancer 63 APOE e4 gene 63 axillary lymph nodes 63 FXTAS 63 carotid plaque 63 atypical ductal hyperplasia 63 genes predisposing 63 gallstone disease 63 colorectal neoplasms 63 TP# mutation 63 CC genotype 63 ASCUS 63 poorer prognosis 63 shorter telomeres 63 penetrance 63 cognitively normal 63 HER2 positive tumors 63 CYP#C# * 63 Asymptomatic 63 monozygotic twins 63 ADPKD 63 thyroid hormone levels 63 C#Y 63 familial ALS 63 V Leiden 63 untreated celiac disease 63 IgA deficiency 63 serous ovarian cancer 63 Fragile X gene 63 ductal cancer 63 telomere lengths 63 rs# [001] 63 GSTM1 63 gene mutations 63 apolipoprotein E 63 BMPR2 63 MetS 63 TCF#L# gene 63 premenopausal breast cancer 63 HGPIN 63 anal cancers 63 variant alleles 63 gene variants 63 bladder cancers 63 colorectal tumors 63 BRIP1 63 hamartomas 63 mesotheliomas 63 ovarian tumors 63 TP# mutations 62 spontaneous preterm delivery 62 monozygotic twin 62 prostate pancreatic 62 genetic polymorphisms 62 invasive carcinoma 62 hereditary breast cancer 62 MYH9 gene 62 chromosomal abnormalities 62 varicoceles 62 apolipoprotein E gene 62 HbF 62 TCF#L# 62 elevated triglyceride levels 62 thyrotropin levels 62 SE alleles 62 operable breast cancer 62 GSTT1 62 bilateral oophorectomy 62 faulty BRCA genes 62 K ras mutations 62 CIN3 62 chorioamnionitis 62 mutation 62 neurological abnormalities 62 invasive ductal 62 gene BRCA2 62 hereditary predisposition 62 familial adenomatous polyposis 62 colorectal adenoma 62 gene variation 62 FGFR2 62 aneuploidy 62 endometrial hyperplasia 62 rs# [002] 62 TT genotype 62 colon tumors 62 gene variant 62 LRP5 62 gynecologic malignancy 62 varicocele 62 ABCB1 62 premenopausal 62 nonmelanoma skin cancer 62 CDH1 62 CCR5 delta# 62 BRAF V#E 62 genetic variant 62 singleton pregnancies 62 #.#ng/ml 62 familial clustering 62 serum selenium 62 CHEK2 62 G allele 62 nonischemic 62 genetic variants associated 62 cystatin C 62 testosterone supplementation 61 adenocarcinomas 61 preterm deliveries 61 BARD1 61 neoplasias 61 dizygotic twins 61 colorectal adenomas 61 ε4 61 microdeletions 61 familial hypercholesterolemia 61 ApoE 61 G#S mutation 61 ICDs implanted 61 somatic mutations 61 #q# deletion 61 mtDNA mutations 61 endometrial carcinoma 61 heterozygotes 61 colorectal carcinoma 61 sporadic ALS 61 oropharyngeal cancer 61 breast cancer gene mutation 61 CIN2 + 61 missense mutations 61 HER2 positive cancers 61 thrombophilia 61 subclinical atherosclerosis 61 carotid plaques 61 lobular carcinoma 61 BRCA carriers 61 HGPS 61 BRCA 61 inherited predisposition 61 hormone receptor negative 61 mitochondrial mutations 61 androgen deficiency 61 NAFLD 61 mutated K ras 61 KIF6 gene 61 undergone radical prostatectomy 61 leiomyomas 61 abnormal glucose tolerance 61 recurrent miscarriages 61 BRCA1 BRCA2 61 CDKN2A 61 lung adenocarcinomas 61 Adjuvant chemotherapy 61 chronic prostatitis 61 pre menopausal 61 micrometastases 61 intestinal polyps 61 breast carcinoma 61 GSTP1 61 premalignant 61 Digital Mammographic Imaging 61 liver transplant recipients 61 p# mutation 61 postoperative delirium 61 variant allele 61 Uterine cancer 61 extracolonic findings 61 mosaicism 61 gene APOE 61 APOE 61 recurrent VTE 61 PCa 61 hydroxyvitamin D levels 61 adenomas 61 pre eclamptic 61 androgen deprivation 61 breast cancer subtypes 61 hormone therapy estrogen 61 de ath 61 APOE genotype 61 proband 61 homozygotes 61 spontaneous preterm birth 61 Leydig cell 61 recurrent UTI 61 apolipoprotein E4 61 Cholangiocarcinoma 61 UGT#A# * 61 Wwox 61 clinically insignificant 61 carotid stenosis 61 perimenopausal women 61 contralateral breast 61 cranial irradiation 61 undergoing radical prostatectomy 61 nodal metastases 61 colorectal cancer incidence 61 seropositivity 60 abnormal Pap test 60 BRCA genes 60 cerebral microbleeds 60 prostate cancers 60 slow metabolizers 60 congenital abnormalities 60 mutations 60 precancerous cervical 60 malignant neoplasm 60 BRAF mutations 60 nondiabetic 60 polyp recurrence 60 lymph node metastases 60 knee OA 60 cisplatin resistant 60 denser breasts 60 T1DM 60 FGFR2 gene 60 urothelial cancer 60 esophageal squamous cell carcinoma 60 nonpregnant women 60 epigenetic changes 60 chromosomal rearrangement 60 bowel polyps 60 NKX2 60 allele frequencies 60 genetic abnormalities 60 SHBG levels 60 transferrin saturation 60 normal karyotype 60 microbleeds 60 PSA velocity 60 AAT deficiency 60 squamous cell lung cancer 60 HER2 expression 60 heterozygous 60 cervical lesions 60 pre cancerous polyps 60 folate intake 60 GISTs 60 gestational diabetes mellitus 60 venous thrombosis 60 colorectal cancer CRC 60 VUR 60 BRCA2 breast cancer 60 invasive breast cancer 60 CHD mortality 60 neuroblastomas 60 gestational hypertension 60 uterine cancers 60 urothelial carcinoma 60 Hurthle cell 60 BRAC2 60 estrogen metabolites 60 prostate carcinoma 60 locoregional recurrence 60 nodal metastasis 60 EBV infection 60 testicular tumors 60 benign breast 60 HLA genes 60 histological subtype 60 prostate adenocarcinoma 60 mammographic density 60 hepatocellular carcinomas 60 coinfection 60 atherosclerotic lesions 60 NNRTI resistance 60 sarcosine 60 breast cancer susceptibility genes 60 colorectal polyp 60 Epidemiologic studies 60 EGFR mutation 60 urethritis 60 cell carcinomas 60 RBP4 60 Uterine fibroids 60 Clusterin 60 coronary calcification 60 progesterone receptor negative 59 rs# [004] 59 LRRK2 gene 59 promoter methylation 59 endogenous estrogen 59 endometrial cancer 59 TMEM#B 59 VTEs 59 aortic atherosclerosis 59 sentinel nodes 59 LV dysfunction 59 Endometrial 59 DQB1 * 59 uveal melanoma 59 plasma folate 59 transfusion syndrome 59 seminomas 59 C. trachomatis 59 benign growths 59 preterm delivery 59 microcephalin 59 parous women 59 Genetic variants 59 prophylactic mastectomies 59 thyroid cancers 59 mIU L 59 leukaemias 59 lung adenocarcinoma 59 dizygotic 59 beta carotene supplementation 59 mutated gene 59 ductal lobular 59 2D 4D ratio 59 CaP 59 elevated hsCRP 59 breast cancers 59 thyroid nodules 59 Leitzmann 59 meningiomas 59 lobular involution 59 elevated LDH 59 precursor lesions 59 gene polymorphisms 59 APOE4 gene 59 obstructive coronary artery 59 BRAF mutation 59 carcinoid tumor 59 born preterm 59 COX2 59 GNAQ 59 multivariable adjusted 59 CGG repeats 59 SLNB 59 neuroblastoma tumors 59 gene predisposing 59 proximal colon 59 bowel cancers 59 epithelial ovarian cancer 59 Helicobacter pylori infection 59 invasive lobular 59 Chlamydia infection 59 breast endometrial 59 de novo mutations 59 hyperplastic 59 oesophageal adenocarcinoma 59 Ashkenazi Jewish 59 gastric cardia 59 shorter telomere length 59 CVD mortality 59 mammary cancers 59 GnRH agonists 59 GBV C 59 congenital malformations 59 atrophic gastritis 59 cTnT 59 endometriosis ovarian cysts 59 confidence interval #.#-#.# 59 PARP inhibition 59 supratentorial 59 gene polymorphism 59 breast carcinomas 59 heterotaxy 59 osteosarcomas 59 ERBB2 59 lymph node involvement 59 polycystic ovary syndrome 59 IKZF1 59 MC1R 59 hypermethylation 59 TACI mutations 59 malignant lesions 59 microdeletion 59 pathogenic mutations 59 cerebral infarction 59 seminoma 59 HPV# 59 KRAS mutation 59 Basal Cell 59 precancerous tumors 59 Li Fraumeni syndrome 59 primary ovarian insufficiency 59 HER2 amplification 59 neurodevelopmental impairment 59 renal tumors 59 homozygosity 59 #q# [001] 59 sFlt 1 59 asymptomatic PAD 59 troponin T 59 congenital anomalies 59 HER2 overexpression 59 estrogen receptor positive 59 tumor histology 59 ORMDL3 59 genetic variants 59 basal cell carcinoma BCC 59 undescended testes 59 white matter hyperintensities 59 medulloblastomas 59 grade gliomas 59 coinfected 59 disease NAFLD 59 anovulatory infertility 59 STAT4 58 estrogen progestin therapy 58 Hashimoto thyroiditis 58 ovarian cancers 58 malignant prostate 58 CMV infection 58 estrogen receptor ER 58 polycystic ovarian syndrome PCOS 58 nulliparous women 58 Hepatitis B virus 58 mutated genes 58 highest quintile 58 chromosomal aberrations 58 HLA B# 58 ovarian hormones 58 abdominal adiposity 58 persistent pulmonary hypertension 58 hypermethylated 58 testicular cancers 58 Young Adults CARDIA 58 metastatic prostate 58 lobular 58 histologic subtype 58 FeNO 58 MMSE scores 58 fetal chromosomal 58 KRAS oncogene 58 nulliparous 58 breast cancer metastasis 58 SORL1 58 CP CPPS 58 antigen PSA 58 irregular menstrual cycles 58 arterial calcification 58 colonic mucosa 58 HLA DRB1 * 58 BRCA deficient 58 pancreatic lung 58 fetuin 58 PGDH 58 Ovary removal 58 molecular abnormalities 58 allele 58 uterine tumors 58 YKL 58 CFTR gene 58 neurologic complications 58 peritoneal cancer 58 nonalcoholic steatohepatitis NASH 58 infantile hemangiomas 58 NF1 58 Trichomonas vaginalis 58 biochemical relapse 58 antiphospholipid antibodies 58 transthyretin 58 CNVs 58 poor metabolizers 58 squamous cell cancers 58 epithelial tumors 58 colon cancers 58 rs# [003] 58 Colon polyps 58 noncancer 58 AML MDS 58 cryptorchidism 58 KIF6 gene variant 58 NR#A# 58 breast lesions 58 Adenomas 58 infarcts 58 mutant mice lacking 58 chromosomal alterations 58 genetic mutations 58 deleterious mutation 58 cervical lymph nodes 58 Heterozygous 58 diffuse gastric 58 IPAH 58 metabolic syndrome MetS 58 obese postmenopausal 58 Polycystic ovary syndrome PCOS 58 dopamine receptor gene 58 dysglycemia 58 fetal malformations 58 overt hypothyroidism 58 cardiovascular mortality 58 microscopic hematuria 58 nonhereditary 58 univariate analyzes 58 glycated hemoglobin levels 58 situ LCIS 58 vertebral fracture 58 epithelial ovarian 58 hypovitaminosis D 58 Cowden syndrome 58 benign lesions 58 CYP#C# [001] 58 epididymitis 58 anaplastic lymphoma kinase 58 basal cell carcinomas 58 metaplasia 58 LRAT 58 ependymomas 58 gene mutation 58 susceptibility genes 58 rectal cancers 58 axillary nodes 58 elevated homocysteine 58 malignancies 58 lymphatic cancers 58 B7 H3 58 adnexal mass 58 deCODE BreastCancer TM 58 apoE 58 PTEN mutation 58 perioperative complications 58 thalassemia trait 58 prostate carcinogenesis 58 deleterious mutations 58 habitual snoring 58 nondemented 58 preeclamptic 58 NAT2 58 SUVmax 58 SOD2 gene 58 type2 diabetes 58 MTHFR gene 58 LRRK2 mutation 58 GIST tumors 58 Dietary Modification Trial 58 postmenopausal hormone therapy 58 metachronous 58 SHBG 58 spontaneous mutations 58 germline mutation 58 distant metastases 58 microsatellite instability 58 peritoneal carcinomatosis 58 Epstein Barr virus EBV 58 papillary thyroid cancer 58 neurodevelopmental outcome 58 microvascular disease 58 medulloblastoma tumors 58 Leydig cells 58 macrosomia 58 Klinefelter syndrome 58 HIV HCV coinfected 58 neurofibromas 58 ovarian carcinoma 58 rectal gonorrhea 58 5 HTTLPR 58 relapsed ALL 58 anal lesions 58 Subgroup analyzes 57 cervical carcinoma 57 atopic 57 adiponectin levels 57 alleles 57 postmenopausal hormone 57 Hilakivi Clarke 57 breast cancer recurrences 57 CagA 57 ZNF# 57 axillary dissection 57 ovarian dysfunction 57 Papillary 57 HBsAg 57 IDH1 mutation 57 asymptomatic carotid stenosis 57 serum estradiol 57 undergoing bariatric surgery 57 colorectal bowel 57 nonmelanoma 57 acute leukemias 57 Cytogenetic 57 systemic lupus erythematosus SLE 57 tibolone 57 underwent radical prostatectomy 57 diagnosed prenatally 57 tumor recurrence 57 Prostatitis 57 telomere length 57 abnormal mammograms 57 CHEK2 gene 57 heterozygote 57 severe periodontitis 57 stratifying patients 57 abnormal mammogram 57 elevated serum creatinine 57 oral clefts 57 TRAF1 C5 57 coronary artery calcification 57 sCJD 57 neural tube defect 57 mutated BRCA 57 gastric cancers 57 GBM tumors 57 Folate deficiency 57 NMIBC 57 tanned indoors 57 FMR1 gene 57 carotid IMT 57 inherited gene mutation 57 FMR1 57 euthyroid 57 vulvar cancers 57 susceptibility loci 57 frequently benign tumor 57 homozygous 57 lymph node metastasis 57 liver metastasis 57 PTEN mutations 57 premalignant lesions 57 cardioembolic stroke 57 brain lesions 57 Multivariate analysis 57 CYP#C# [002] 57 kidney allograft 57 coronary artery calcium 57 NP CRNs 57 untreated hypothyroidism 57 colorectal cancers 57 nondiabetics 57 ovarian breast 57 SNP rs# [001] 57 nonischemic cardiomyopathy 57 nonmetastatic 57 esophageal adenocarcinoma 57 fasting glucose levels 57 nondiabetic patients 57 premenopausal women 57 Malignancies 57 ERCC1 57 thiopurine 57 microscopic colitis 57 apoE4 57 urine cytology 57 BRCA1 gene mutation 57 DRB1 * 57 lobular carcinomas 57 azoospermia 57 PCNSL 57 nonvertebral fractures 57 PON1 57 DNA methylation patterns 57 endometrial 57 gastric adenocarcinoma 57 colon rectal 57 neuroglobin 57 sarcomatoid 57 multivariate analyzes 57 Autoantibodies 57 idiopathic PAH 57 GSTM1 gene 57 gastric carcinoma 57 taxane therapy 57 monozygotic 57 elevated LDL cholesterol 57 affective psychoses 57 ductal carcinomas 57 baseline LDH 57 endostatin 57 grade cervical intraepithelial 57 undergone hysterectomy 57 folate deficiency 57 multivariate logistic regression 57 genital tract infections 57 MnSOD 57 premature ovarian 57 carcinoid 57 ADH1B * 57 myocardial infarctions 57 intermittent exotropia 57 MYH9 57 microvascular complications 57 C. pneumoniae 57 adenomatous 57 aneuploidies 57 MLL gene 57 chromosomal regions 57 Recurrences 57 Heavy menstrual bleeding 57 pulmonary metastases 57 patients undergoing CABG 57 benign proliferative breast 57 Michael F. Leitzmann 57 Multivariate analyzes 57 angiotensin receptor blockers ARBs 57 BRAF V#E mutation 57 eosinophil count 57 Folic acid supplements 57 methylated genes 57 adjuvant radiotherapy 57 mucinous 57 genetic loci 57 folate supplementation 57 herpesviruses 57 hydroxychloroquine 57 gastrointestinal cancers 57 HER2 amplified 57 gene expression profiles 57 Metastases 57 intensive statin therapy 57 APOC3 57 medically inoperable 57 polymorphisms 57 cervical vaginal 57 chorionic villi 57 familial aggregation 57 genetic polymorphism 57 molecular subtypes 57 NOMID 57 noncardiac 57 hamartoma 57 Myelodysplastic syndromes MDS 57 Complication rates 57 carotid artery thickness 57 multivariable analysis 57 CALHM1 57 gestational diabetes mellitus GDM 57 chromosomal anomalies 57 TEAEs 57 prognostic indicator 57 genetic alterations 57 Inhibin B 57 Ashkenazi Jews 57 palladin 57 colon polyps 57 LVNC 57 femoral neck BMD 57 abnormal Pap smears 57 chromosome abnormalities 57 polymorphism 57 LDL particle 57 microalbuminuria 57 autoantibodies 57 orofacial clefts 57 immunodeficient 57 Sjögren syndrome 57 venous thromboembolism 57 gene amplification 57 LRRK2 mutations 57 Colorectal cancers 57 atherogenic dyslipidemia 57 malignant lymphoma 57 RET PTC rearrangements 57 ApoE gene 57 prostate specific 57 diabetes mellitus DM 57 estrogen receptors 57 chlamydial infections 57 premutation 57 CYP#D# gene 57 PTEN gene 57 mutated BRAF gene 57 hematopoietic cancers 57 PSA screening 57 chlamydia infections 57 LPA gene 57 kidney transplant recipients 57 monoclonal gammopathy 57 susceptibility gene 57 LHRH receptor positive 57 mammary tumors 57 oligodendrogliomas 57 BRCA breast cancer 57 postmenopausal hormones 57 apoC III 57 BRAF gene 57 p#INK#a 57 OGG1 57 CARDIA 57 carcinomas 57 serum IGF 56 Immunohistochemical analysis 56 prostate cancer PCa 56 chromosome #q# [001] 56 invasive lobular carcinoma 56 asymptomatic 56 promoter hypermethylation 56 HPV infections 56 pancreatic cancers 56 squamous cell carcinomas 56 uterine ovarian 56 dose ionizing radiation 56 gene rearrangements 56 chronic HBV 56 esophageal cancers 56 genes CYP#C# 56 elevated triglycerides 56 causative mutation 56 Myocardial infarction 56 CYP#B# 56 extracapsular extension 56 precancerous polyp 56 abnormal pap smears 56 flutamide 56 underwent CABG 56 gene expression patterns 56 prophylactic mastectomy 56 clefting 56 BMD measurements 56 autosomal recessive 56 atopic asthma 56 haplotypes 56 PTEN protein 56 osteoporotic 56 Malignant tumors 56 precocious puberty 56 genetic mutation 56 ALI ARDS 56 underactive thyroid gland 56 neoplasms 56 motor neuron degeneration 56 endocrine therapies 56 childhood leukemias 56 #q#.# [001] 56 ccRCC 56 PSADT 56 serum uric acid 56 aneuploid 56 metastatic lesions 56 abnormal cytology 56 telomere shortening 56 HIV seronegative 56 ALK mutations 56 progestins 56 thrombocytopenic 56 incidentalomas 56 distal colon cancer 56 precancerous colon polyps 56 papillary renal cell carcinoma 56 metabolic abnormalities 56 thromboembolism 56 etiologic 56 breast uterine 56 carotid atherosclerosis 56 grade serous ovarian 56 autosomal dominant inheritance 56 nonsmall cell lung cancer 56 nondepressed 56 estrogen receptor 56 genetic abnormality 56 IGFBP 56 squamous cell carcinoma SCC 56 N. gonorrhoeae 56 CIN2 56 IUGR 56 pelvic lymphadenectomy 56 parkinsonism 56 distant metastasis 56 grade squamous intraepithelial 56 kaempferol 56 probands 56 immunized mice 56 EUS FNA 56 differentially expressed genes 56 curable cancers 56 colonic polyps 56 premature menopause 56 chromosomal disorders 56 karyotypes 56 ovarian pancreatic 56 Genetic predisposition 56 chromosomal instability 56 Genetic variations 56 Tumours 56 flavonoid intake 56 Invasive Breast Cancer 56 anovulatory 56 mammographically 56 HER2 receptor 56 GPC5 56 SPINK1 56 PCA3 scores 56 prognostic factors 56 thromboses 56 recurrent miscarriage 56 HMGA2 56 GRK5 56 parkin gene 56 precancers 56 node metastases 56 ovulatory cycles 56 colorectal tumor 56 β blockers 56 differentiated thyroid 56 HLA DQ2 56 clinicopathologic 56 TIMP 56 radical nephrectomy 56 cardiac troponin T 56 non pledgers 56 BRCA gene 56 thyrotropin 56 Framingham Offspring Study 56 seronegative 56 FGFs 56 JAK2 mutation 56 RhD negative 56 primary cilia 56 CYP#D# 56 RBC folate 56 singleton pregnancy 56 sentinel node biopsy 56 sulphonylureas 56 serum testosterone levels 56 HLA B 56 symptomatic fibroids 56 SNP rs# [002] 56 intima media thickness 56 nonobese 56 LRP6 56 G6PD deficiency 56 neoplastic 56 osteopenic

Back to home page